Cost-Effectiveness of a Cluster Randomised Whole of Systems Trial of Prevention Strategies for Childhood Obesity (WHO STOPS)
In brief
Childhood obesity prevention trial cost $314 per student without changing BMI
Across 10 Australian communities, the two-year program cost government an average of $314 per student and did not change children's body mass index. It showed potential to improve health-related quality of life and generated an estimated 2 to 58 cents in additional community resources per funding dollar, but whether these gains justify the cost over the long term remains unknown.
- Journal
- Journal of obesity (Q2)
- Published
- 1 January 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Ha N D Le, Cadeyrn J Gaskin, Claudia Strugnell, Kristy A Bolton, Liliana Orellana, Penny Fraser, et al.
- PMID
- 43065166
- DOI
- 10.1155/jobe/4880792
Why clinicians should know about it
- Picked for Public Health, Environmental and Occupational Health (top studies of the week, 22 November 2026): Evaluates costs and outcomes of community-wide childhood obesity prevention
Abstract
BACKGROUND: To report a cost-effectiveness analysis of the Whole of Systems Trial of Prevention Strategies for Childhood Obesity (WHO STOPS) intervention, which was a cluster randomised trial aiming to prevent obesity in primary school children from Victoria, Australia. METHODS: Ten communities were randomly allocated (1:1) to the intervention and control communities in 2015. A cost-effectiveness analysis and the resources generated from the project investment were conducted from the government and societal perspectives. Costs (AUD, 2026) were estimated from project team records, organisation records, staff interviews and questionnaires. Outcomes were measured as body mass index (BMI)z (estimated using students' height and weight measured in 2015, 2017 and 2019) and children's health-related quality of life (HRQoL) (measured using the Pediatric Quality of Life Inventory 4.0). RESULTS: Over the 2-year period, the average cost per community was $382,905 for government ($314 per student) and $398,964 for society ($328 per student). No effect was found for BMIz. It costs $138 per student (government) or $144 (society) to achieve a change of one point in children's HRQoL from 2017 to 2015. For every dollar of project funding, an additional $0.02-0.58 of community resources was generated. CONCLUSIONS: WHO STOPS was not cost-effective in changing BMIz but had the potential to change children's HRQoL and build community capacity to generate investment over and above the initial funding. Further studies should explore the long-term cost-benefit of such system interventions. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12616000980437.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.